🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Adherence to Enteral Nutrition

Recruitingn/aAges 18 Years - 100 YearsAllInstitut Curie
NCT07571564 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Malnutrition is a major challenge in cancer nutrition, affecting approximately 40% of cancer patients and having negative consequences on treatment efficacy, quality of life, and prognosis. It must be detected and managed early, based on clinical and laboratory criteria defined by the HAS recommendations. To address this, several nutritional strategies are available, ranging from fortified oral feeding to artificial nutrition. Enteral nutrition, which is more physiological and carries fewer risks than parenteral nutrition, is recommended as the first-line treatment. Tools such as personalized care plans and guidelines help tailor patient care. However, enteral nutrition remains underutilized in clinical practice, despite the recommendations. The ADHENUTE study, conducted at the Institut Curie, showed low compliance with recommendations (31%) and a tendency to favor oral nutritional sup

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients hospitalized (including those in the day hospital) in a medical oncology unit; * Adults; * Men or women; * Patients for whom enteral nutrition is indicated according to SFNCM recommendations; Exclusion Criteria: * Minors (under 18 years of age) * Patients receiving end-of-life palliative care * Individuals deprived of their liberty or under legal guardianship (including conservatorship); * Adults under judicial protection; * Inability to participate in the study for geographical, social, or psychological reasons. * Persons referred to in Articles L. 1121-5 through L. 1121-8 and L. 1122-1-2 of the Public Health Code (e.g., minors, adults under guardianship, etc.). * Patients who do not speak or understand French.
💊

What it tests

  • Not listed
📍

Where

1 site
Institut Curie
Paris, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy